RE: New Investor? Think you have missed the boat?1 Oct 2020 16:08
https://www.youtube.com/watch?v=amjoVe7ihck&feature=youtu.be - video of recent presentation.
48:45
M&A strategy - "We are clear what we need to do.
We are looking to add revenues and to add to profitability of the group.
By doing this we will 'offset' or 'hedge' the risk associated with the loss of C-19 revenues at some point in the future."
(at last, the CEO talking about the number 1 subject that dissuades new investors from investing).
"I would hasten to add that we do not see that happening near term and believe, unfortunately, that Covid-19 testing will be here for some time to come."
So the company has got themselves as close as possible to PHE and those persons uniquely qualified to state the future needs of the health service in terms of testing and test capabilities.
They are meeting these needs by developing products (e.g. Winterplex) that the govnt. say they want at break neck speed.
(If the British Govnt's testing requirements are being met by NCYT's new products, - I don't see how other govnts requirements would differ materially).
The company are also working with Astra and GSK at Cambridge.
If there is a better placed Biotech to understand the needs of testers and testing, I'd like to hear from them.
So when Graham states they are 'hedging' against losing income from C-19 revenues "at some point in the future"
and that "we do not see that (loss of C-19 revenues) happening near term", for me that is unequivocal.
There are 2 maybe more products in the pipeline, so lets hope they launch soon.